The Use of Pharmacoeconomics in the US Healthcare System

DOI Web Site 1 Citations

Bibliographic Information

Other Title
  • 米国ヘルスケアシステムにおける薬剤経済学の利用状況
  • Use of Pharmacoeconomics in the US Healthcare System

Search this article

Description

<p>Healthcare expenditures in the United States are growing by almost 10% a year, and reached approximately ＄1.3 trillion in 2001. Drugs accounted for about 10% of this amount However, the market for prescription drugs is growing at a rate of 15.7%, and has exhibited much higher growth than overall health expenditures. The expansion of managed care since the nineties has brought with it a variety of means to control health spending. Originally just in hospitals, MCOs, PBMs, and physicians groups have now also formed pharmaceutical and therapeutics (P&T) committees in order to list new drugs in and update formularies. The use of pharmacoeconomics by P&T committees in formulary control has been increasing in recent years. Pharmacoeconomic approaches to evaluating physician activities, such as the cost-effectiveness of prescribing habits, is also growing more common in hospitals and other medical care settings. Pharmacist associations and academic societies with an interest in managed care are now providing educational programs for their members and related professions, as well as guidelines to standardize the use of pharmacoeconomic analysis. Observing practical applications of pharmacoeconomics, and its results, in the US provides useful lessons for improving the use of pharmacoeconomics in the health services in Japan as well.</p>

Journal

Citations (1)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top